| 1. | Masurekar, A. N., Parker, C. A., Shanyinde, M., Moorman, A. V., Hancock, J. P., Sutton, R., Ancliff, P. J., Morgan, M., Goulden, N. J., Fraser, C., Hoogerbrugge, P. M., Revesz, T., Darbyshire, P. J., Krishnan, S., Love, S. B. and Saha, V. Outcome of Central Nervous System Relapses In Childhood Acute Lymphoblastic Leukaemia - Prospective Open Cohort Analyses of the ALLR3 Trial. PloS One. 2014. 9, e108107. [PubMed] |
2. | van, d. e. r., Zaliova, M., Mottadelli, F., De, L., Te, K., Harrison, C. J., Cave, H., Trka, J., Saha, V., Schrappe, M., Pieters, R., Biondi, A., Valsecchi, M. G., Stanulla, M., den, B. and Cazzaniga, G. IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL. Blood. 2014. 123, 1691-1698. [PubMed] | 3. | Biondi, A., Schrappe, M., De, L., Castor, A., Lucchini, G., Gandemer, V., Pieters, R., Stary, J., Escherich, G., Campbell, M., Li, C. K., Vora, A., Arico, M., Rottgers, S., Saha, V. and Valsecchi, M. G. Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study. The Lancet. Oncology. 2012. 13, 936-945. [PubMed] | 4. | Schrappe, M., Hunger, S. P., Pui, C. H., Saha, V., Gaynon, P. S., Baruchel, A., Conter, V., Otten, J., Ohara, A., Versluys, A. B., Escherich, G., Heyman, M., Silverman, L. B., Horibe, K., Mann, G., Camitta, B. M., Harbott, J., Riehm, H., Richards, S., Devidas, M. and Zimmermann, M. Outcomes after induction failure in childhood acute lymphoblastic leukemia. The New England Journal of Medicine. 2012. 366, 1371-1381. [PubMed] | 5. | Holland, M., Castro, F. V., Alexander, S., Smith, D., Liu, J., Walker, M., Bitton, D., Mulryan, K., Ashton, G., Blaylock, M., Bagley, S., Connolly, Y., Bridgeman, J., Miller, C., Krishnan, S., Dempsey, C., Masurekar, A., Stern, P., Whetton, A. and Saha, V. RAC2, AEP, and ICAM1 expression are associated with CNS disease in a mouse model of pre-B childhood acute lymphoblastic leukemia. Blood. 2011. 118, 638-649. [PubMed] | 6. | van, D., Horsley, S., Colman, S., Anderson, K., Bateman, C., Kempski, H., Zuna, J., Eckert, C., Saha, V., Kearney, L., Ford, A. and Greaves, M. Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia. Blood. 2011. 117, 6247-6254. [PubMed] | 7. | Parker, C., Waters, R., Leighton, C., Hancock, J., Sutton, R., Moorman, A. V., Ancliff, P., Morgan, M., Masurekar, A., Goulden, N., Green, N., Revesz, T., Darbyshire, P., Love, S. and Saha, V. Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial. Lancet. 2010. 376, 2009-2017. [PubMed] | 8. | Offman, M. N., Krol, M., Patel, N., Krishnan, S., Liu, J., Saha, V. and Bates, P. A. Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity. Blood. 2011. 117, 1614-1621. [PubMed] | 9. | Arico, M., Schrappe, M., Hunger, S. P., Carroll, W. L., Conter, V., Galimberti, S., Manabe, A., Saha, V., Baruchel, A., Vettenranta, K., Horibe, K., Benoit, Y., Pieters, R., Escherich, G., Silverman, L. B., Pui, C. H. and Valsecchi, M. G. Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2010. 28, 4755-4761. [PubMed] | 10. | Patel, N., Krishnan, S., Offman, M. N., Krol, M., Moss, C. X., Leighton, C., van, D., Holland, M., Liu, J., Alexander, S., Dempsey, C., Ariffin, H., Essink, M., Eden, T. O., Watts, C., Bates, P. A. and Saha, V. A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase. The Journal of Clinical Investigation. 2009. 119, 1964-1973. [PubMed] | 11. | Saha V. Simplifying treatment for children with ALL. Lancet. 2007. 369, 82-83. [PubMed] | 12. | Strefford, J. C., van, D., Robinson, H. M., Worley, H., Yiannikouris, O., Selzer, R., Richmond, T., Hann, I., Bellotti, T., Raghavan, M., Young, B. D., Saha, V. and Harrison, C. J. Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21. Proceedings of the National Academy of Sciences of the United States of America. 2006. 103, 8167-8172. [PubMed] | 13. | Bellotti, T., Luo, Z., Gammerman, A., Van, D. and Saha, V. Qualified predictions for microarray and proteomics pattern diagnostics with confidence machines. International Journal of Neural Systems. 2005. 15, 247-258. [PubMed] | 14. | Jones, L. K. and Saha, V. Philadelphia positive acute lymphoblastic leukaemia of childhood. British Journal of Haematology. 2005. 130, 489-500. [PubMed] | 15. | Roy, A., Cargill, A., Love, S., Moorman, A. V., Stoneham, S., Lim, A., Darbyshire, P. J., Lancaster, D., Hann, I., Eden, T. and Saha, V. Outcome after first relapse in childhood acute lymphoblastic leukaemia - lessons from the United Kingdom R2 trial. British Journal of Haematology. 2005. 130, 67-75. [PubMed] | 16. | van, D., Bellotti, T., Luo, Z., Jones, L. K., Patel, N., Yiannikouris, O., Hill, A. S., Hubank, M., Kempski, H., Fletcher, D., Chaplin, T., Foot, N., Young, B. D., Hann, I. M., Gammerman, A. and Saha, V. Prospective gene expression analysis accurately subtypes acute leukaemia in children and establishes a commonality between hyperdiploidy and t(12;21) in acute lymphoblastic leukaemia. British Journal of Haematology. 2005. 130, 26-35. [PubMed] | 17. | Bury, J., Hurt, C., Roy, A., Cheesman, L., Bradburn, M., Cross, S., Fox, J. and Saha, V. LISA: a web-based decision-support system for trial management of childhood acute lymphoblastic leukaemia. British Journal of Haematology. 2005. 129, 746-754. [PubMed] | 18. | Roy, A., Bradburn, M., Moorman, A. V., Burrett, J., Love, S., Kinsey, S. E., Mitchell, C., Vora, A., Eden, T., Lilleyman, J. S., Hann, I. and Saha, V. Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial. British Journal of Haematology. 2005. 129, 35-44. [PubMed] | 19. | Bury, J., Hurt, C., Roy, A., Bradburn, M., Cross, S., Fox, J. and Saha, V. A quantitative and qualitative evaluation of LISA, a decision support system for chemotherapy dosing in childhood acute lymphoblastic leukaemia. Studies in Health Technology and Informatics. 2004. 107, 197-201. [PubMed] | 20. | Zuna, J., Ford, A. M., Peham, M., Patel, N., Saha, V., Eckert, C., Kochling, J., Panzer-Grumayer, R., Trka, J. and Greaves, M. TEL deletion analysis supports a novel view of relapse in childhood acute lymphoblastic leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 2004. 10, 5355-5360. [PubMed] | 21. | van, D. and Saha, V. Molecular techniques to improve outcome in childhood ALL. Methods in Molecular Medicine. 2004. 91, 111-122. [PubMed] | 22. | Stoneham, S., Lennard, L., Coen, P., Lilleyman, J. and Saha, V. Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia. British Journal of Haematology. 2003. 123, 100-102. [PubMed] | 23. | Gandhi, M., Rao, K., Chua, S., Saha, V., Lilleyman, J. and Shankar, A. Routine blood counts in children with acute lymphoblastic leukaemia after completion of therapy: are they necessary? British Journal of Haematology. 2003. 122, 451-453. [PubMed] | 24. | Patel, N., Goff, L. K., Clark, T., Ford, A. M., Foot, N., Lillington, D., Hing, S., Pritchard-Jones, K., Jones, L. K. and Saha, V. Expression profile of wild-type ETV6 in childhood acute leukaemia. British Journal of Haematology. 2003. 122, 94-98. [PubMed] | 25. | Jones, L. K. and Saha, V. Chromatin modification, leukaemia and implications for therapy. British Journal of Haematology. 2002. 118, 714-727. [PubMed] | 26. | Lowdell, M. W., Craston, R., Samuel, D., Wood, M. E., O'Neill, E., Saha, V. and Prentice, H. G. Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells. British Journal of Haematology. 2002. 117, 821-827. [PubMed] | 27. | Saha V. Making paediatric oncological research relevant. Hospital Medicine. 2002. 63, 54. [PubMed] |